Venetoclax, the First BCL-2 Inhibitor for Use in Patients With Chronic Lymphocytic Leukemia

被引：0
|
作者：
Seymour, John [1 ,2 ,3 ]
机构：
[1] Peter MacCallum Canc Ctr, Clin Res, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Ctr, Dept Haematol, Melbourne, Vic, Australia
[3] Royal Melbourne Hosp, Melbourne, Vic, Australia
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2019年 / 17卷 / 08期
关键词：
NAVITOCLAX; RITUXIMAB;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：440 / 443
页数：4
相关论文
共 50 条
  • [1] VENETOCLAX: BCL-2 INHIBITION FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
    Del Poeta, G.
    Postorino, M.
    Pupo, L.
    Del Principe, M. I.
    Dal Bo, M.
    Bittolo, T.
    Buccisano, F.
    Mariotti, B.
    Iannella, E.
    Maurillo, L.
    Venditti, A.
    Gattei, V.
    de Fabritiis, P.
    Cantonetti, M.
    Amadori, S.
    DRUGS OF TODAY, 2016, 52 (04) : 249 - 260
  • [2] Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma
    Koji Izutsu
    Kazuhito Yamamoto
    Koji Kato
    Takayuki Ishikawa
    Noriko Fukuhara
    Yasuhito Terui
    Ilseung Choi
    Kathryn Humphrey
    Su Young Kim
    Sumiko Okubo
    Natsumi Ogawa
    Yasuko Nishimura
    Ahmed Hamed Salem
    Dai Maruyama
    International Journal of Hematology, 2021, 113 : 370 - 380
  • [3] Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma
    Izutsu, Koji
    Yamamoto, Kazuhito
    Kato, Koji
    Ishikawa, Takayuki
    Fukuhara, Noriko
    Terui, Yasuhito
    Choi, Ilseung
    Humphrey, Kathryn
    Kim, Su Young
    Okubo, Sumiko
    Ogawa, Natsumi
    Nishimura, Yasuko
    Salem, Ahmed Hamed
    Maruyama, Dai
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (03) : 370 - 380
  • [4] Pharmacokinetics of Venetoclax, a Novel BCL-2 Inhibitor, in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma
    Salem, Ahmed Hamed
    Agarwal, Suresh K.
    Dunbar, Martin
    Enschede, Sari L. Heitner
    Humerickhouse, Rod A.
    Wong, Shekman L.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (04): : 484 - 492
  • [5] Bcl-2 and apoptosis in chronic lymphocytic leukemia
    Aaron D. Schimmer
    Irene Munk-Pedersen
    Mark D. Minden
    John C. Reed
    Current Treatment Options in Oncology, 2003, 4 (3) : 211 - 218
  • [6] Characterization of LP-118, a Novel Small Molecule Inhibitor of Bcl-2 and Bcl-Xl in Chronic Lymphocytic Leukemia Resistant to Venetoclax
    Ravikrishnan, Janani
    Muhowski, Elizabeth M.
    Lai, Tzung-Huei
    Misra, Shrilekha
    Rohena, Daisy Diaz
    Tan, Felai
    Chen, Yi
    Anthony, Stephen P.
    Chen, Yu
    Shen, Yue
    Byrd, John C.
    Sampath, Deepa
    Woyach, Jenniffer A.
    BLOOD, 2021, 138
  • [7] First in Human Response of BCL-2 Inhibitor Venetoclax in T-Cell Prolymphocytic Leukemia
    Boidol, Bernd
    Kornauth, Christoph
    van der Kouwe, Emiel
    Prutsch, Nicole
    Kazianka, Lukas
    Hoermann, Gregor
    Hopfinger, Georg
    Hauswirth, Alexander
    Aretin, Marie-Bernadette
    Sperr, Wolfgang R.
    Valent, Peter
    Simonitsch-Klupp, Ingrid
    Morrigl, Richard
    Merkel, Olaf
    Kenner, Lukas
    Jaeger, Ulrich
    Kubicek, Stefan
    Staber, Philipp Bernhard
    BLOOD, 2017, 130
  • [8] Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
    Roberts, Andrew W.
    Davids, Matthew S.
    Pagel, John M.
    Kahl, Brad S.
    Puvvada, Soham D.
    Gerecitano, John F.
    Kipps, Thomas J.
    Anderson, Mary Ann
    Brown, Jennifer R.
    Gressick, Lori
    Wong, Shekman
    Dunbar, Martin
    Zhu, Ming
    Desai, Monali B.
    Cerri, Elisa
    Enschede, Sari Heitner
    Humerickhouse, Rod A.
    Wierda, William G.
    Seymour, John F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (04): : 311 - 322
  • [9] BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia
    Perini, Guilherme Fleury
    Pellegrino Feres, Carolina Cristina
    Cardoso Teixeira, Larissa Lane
    Hamerschlak, Nelson
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (08)
  • [10] BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia
    Guilherme Fleury Perini
    Carolina Cristina Pellegrino Feres
    Larissa Lane Cardoso Teixeira
    Nelson Hamerschlak
    Current Treatment Options in Oncology, 2021, 22
12345